D.E. Shaw & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $90.9M | Buy |
|
|||||
|
2025
Q2 | $35.3M | Sell |
|
|||||
|
2025
Q1 | $78.3M | Sell |
|
|||||
|
2024
Q4 | $85.4M | Buy |
|
|||||
|
2024
Q3 | $91.4M | Buy |
|
|||||
|
2024
Q2 | $67.9M | Buy |
|
|||||
|
2024
Q1 | $15.5M | Buy |
|
|||||
|
2023
Q4 | $18.3M | Sell |
|
|||||
|
2023
Q3 | $36.1M | Sell |
|
|||||
|
2023
Q2 | $47.2M | Buy |
|
|||||
|
2023
Q1 | $46.3M | Buy |
|
|||||
|
2022
Q4 | $41.9M | Buy |
|
|||||
|
2022
Q3 | $30.3M | Buy |
|
|||||
|
2022
Q2 | $19.8M | Buy |
|
|||||
|
2022
Q1 | $2.43M | Sell |
|
|||||
|
2021
Q4 | $7.86M | Buy |
|
|||||
|
2021
Q3 | $6.24M | Sell |
|
|||||
|
2021
Q2 | $6.17M | Sell |
|
|||||
|
2021
Q1 | $11M | Buy |
|
|||||
|
2020
Q4 | $8.38M | Sell |
|
|||||
|
2020
Q3 | $24.8M | Buy |
|
|||||
|
2020
Q2 | $16.9M | Sell |
|
|||||
|
2020
Q1 | $25.1M | Buy |
|
|||||
|
2019
Q4 | $2.15M | Sell |
|
|||||
|
2019
Q3 | $2.15M | Buy |
|
|||||
|
2019
Q2 | $998K | Buy |
|
|||||
|
2019
Q1 | $1.05M | Sell |
|
|||||
|
2018
Q4 | $2.68M | Buy |
|
|||||
|
2018
Q3 | $765K | Sell |
|
|||||
|
2018
Q2 | $8.23M | Sell |
|
|||||
|
2018
Q1 | $32.3M | Sell |
|
|||||
|
2017
Q4 | $34.6M | Sell |
|
|||||
|
2017
Q3 | $115M | Buy |
|
|||||
|
2017
Q2 | $58.5M | Buy |
|
|||||
|
2017
Q1 | $25.4M | Buy |
|
|||||
|
2016
Q4 | $8.06M | Buy |
|
|||||
|
2016
Q3 | $1.7M | Sell |
|
|||||
|
2016
Q2 | $2.21M | Sell |
|
|||||
|
2016
Q1 | $12.2M | Buy |
|
|||||
|
2015
Q4 | $7.64M | Buy |
|
|||||
|
2015
Q3 | $3.02M | Sell |
|
|||||
|
2015
Q2 | $24.5M | Sell |
|
|||||
|
2015
Q1 | $27.9M | Buy |
|
|||||
|
2014
Q4 | $18.6M | Buy |
|
|||||
|
2014
Q3 | $1.1M | Buy |
|
|||||
|
2014
Q2 | $406K | Sell |
|
|||||
|
2014
Q1 | $5.04M | Buy |
|
|||||
|
2013
Q4 | $444K | Buy |
|
|||||
|
2013
Q3 | $211K | Sell |
|
|||||
|
2013
Q2 | $6.79M | Buy |
|